A research team at Purdue University in the US has developed a new analytical imaging technology that eliminates the need for contrast agents to detect and monitor cerebral vascular disorders and injuries in the brain.

The new approach is based on functional MRI and looks for an intrinsic blood-related MRI signal, which is used as a natural biomarker to track blood flow in a patient.

Cerebral circulation time is the delay that occurs during the travel of intrinsic signals from the internal carotid artery to the internal jugular vein.

“The new non-invasive imaging technology allows continuous monitoring of the circulation time and is comparatively safer as it does not require the imaging agents.”

A prolonged time delay is perceived as blood flow disturbance in the brain, potentially due to a tumour, traumatic brain injury or other brain diseases.

Purdue University Weldon School of Biomedical Engineering assistant professor Yunjie Tong said: “We can compare the signal from symmetric arteries and veins in both hemispheres or neck to assess the cerebrovascular integrity or the balance of blood flow.

“The blood flow should be symmetric between the two sides in a healthy subject.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The cerebral circulation time is commonly calculated using imaging methods such as MRIs that require injection of contrast agents into the patient.

However, these techniques allow measurement during the few seconds following the injection and may cause health problems related to contrast agents.

On the contrary, the new non-invasive imaging technology allows continuous monitoring of the circulation time and is comparatively safer as it does not require the imaging agents.

The new test technology is compatible with existing MRI scanners and other imaging equipment, including near-infrared spectroscopy.

The researchers are planning to partner with various organisations. such as companies and medical institutions, to conduct additional assessments of their imaging method.